Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells.

Simons-Evelyn M, Bailey-Dell K, Toretsky JA, Ross DD, Fenton R, Kalvakolanu D, Rapoport AP.

Blood Cells Mol Dis. 2001 Sep-Oct;27(5):825-9.

PMID:
11783945
2.
3.

PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma.

He F, Yan Q, Fan L, Liu Y, Cui J, Wang J, Wang L, Wang Y, Wang Z, Guo Y, Huang G.

Hum Pathol. 2010 Mar;41(3):415-24. doi: 10.1016/j.humpath.2009.05.016. Epub 2009 Dec 1.

PMID:
19954816
4.

PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.

Park JH, Lin ML, Nishidate T, Nakamura Y, Katagiri T.

Cancer Res. 2006 Sep 15;66(18):9186-95.

5.

PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase.

Dougherty JD, Garcia AD, Nakano I, Livingstone M, Norris B, Polakiewicz R, Wexler EM, Sofroniew MV, Kornblum HI, Geschwind DH.

J Neurosci. 2005 Nov 16;25(46):10773-85.

6.

PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response.

Ayllón V, O'connor R.

Oncogene. 2007 May 24;26(24):3451-61. Epub 2006 Dec 11.

PMID:
17160018
7.

Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cells.

Fukukawa C, Ueda K, Nishidate T, Katagiri T, Nakamura Y.

Genes Chromosomes Cancer. 2010 Oct;49(10):861-72. doi: 10.1002/gcc.20795.

PMID:
20589935
8.

Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.

Singh PK, Srivastava AK, Dalela D, Rath SK, Goel MM, Bhatt ML.

Immunobiology. 2014 Jun;219(6):469-74. doi: 10.1016/j.imbio.2014.02.003. Epub 2014 Feb 25.

PMID:
24629784
9.

The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.

Golay J, Erba E, Bernasconi S, Peri G, Introna M.

J Immunol. 1994 Jul 15;153(2):543-53.

PMID:
8021494
10.

Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.

Golay J, Luppi M, Songia S, Palvarini C, Lombardi L, Aiello A, Delia D, Lam K, Crawford DH, Biondi A, Barbui T, Rambaldi A, Introna M.

Blood. 1996 Mar 1;87(5):1900-11.

11.

CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.

Schattner EJ, Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK, Friedman SM.

J Exp Med. 1995 Nov 1;182(5):1557-65.

12.

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells.

Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kehrl J, Marti G, Ptaszynski K, Wang J, Stetler-Stevenson WG.

Blood. 1997 Mar 1;89(5):1708-15.

13.

Expression and phosphorylation of TOPK during spermatogenesis.

Fujibuchi T, Abe Y, Takeuchi T, Ueda N, Shigemoto K, Yamamoto H, Kito K.

Dev Growth Differ. 2005 Dec;47(9):637-44.

PMID:
16316408
14.

Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.

Zheng Z, Takahashi M, Aoki S, Toba K, Liu A, Osman Y, Takahashi H, Tsukada N, Suzuki N, Nikkuni K, Furukawa T, Koike T, Aizawa Y.

J Exp Clin Cancer Res. 1998 Sep;17(3):251-8.

PMID:
9894758
16.

c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomas.

Hu F, Gartenhaus RB, Zhao XF, Fang HB, Minkove S, Poss DE, Rapoport AP.

Leuk Res. 2013 Apr;37(4):447-54. doi: 10.1016/j.leukres.2012.11.010. Epub 2012 Dec 10.

PMID:
23237560
17.

Characterization of a MAPKK-like protein kinase TOPK.

Matsumoto S, Abe Y, Fujibuchi T, Takeuchi T, Kito K, Ueda N, Shigemoto K, Gyo K.

Biochem Biophys Res Commun. 2004 Dec 17;325(3):997-1004.

PMID:
15541388
18.

Differential expression of CD150/SLAMF1 in normal and malignant B cells on the different stages of maturation.

Gordiienko IM, Shlapatska LM, Kovalevska LM, Sidorenko SP.

Exp Oncol. 2016 Jun;38(2):101-7.

PMID:
27356578
19.

Human peripheral gamma delta T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma tested.

Kaur I, de Jong J, Schell K, Hank J, Fisch P, Sondel PM.

Cell Immunol. 1994 Jun;156(1):54-61.

PMID:
8200042
20.

Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells.

Tomeczkowski J, Beilken A, Frick D, Wieland B, König A, Falk MH, Reiter A, Welte K, Sykora KW.

Blood. 1995 Aug 15;86(4):1469-80.

Supplemental Content

Support Center